All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2025-D-3217
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability
Documents
2
Comments
53
Description
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability
Key Dates
Comment Period OpensJan 12, 2026
Comment Period ClosesMar 14, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Comment Statistics
Total Comments
53
Keywords
CDER
2024-887
Use of Bayesian Methodology
Clinical Trials of Drug and Biological Products
Draft Guidance for Industry; Availability
Open
Data from Regulations.gov